# Peter Arduini

> Peter J. Arduini is President and CEO of GE HealthCare. A former Procter & Gamble sales and marketing employee, he spent fifteen years at GE before taking senior roles at Baxter and Integra LifeSciences. He returned to GE in January 2022 and led GE HealthCare into independent public-company life in January 2023. His public leadership discussions emphasize developing people, continuous learning and operational discipline.

- **Role:** President and Chief Executive Officer at GE HealthCare
- **Organizations:** GE HealthCare, Baxter Healthcare, Integra LifeSciences, Procter & Gamble, Bristol Myers Squibb, AdvaMed, National Italian American Foundation, Susquehanna University
- **Nationality:** American
- **Education:** Bachelor of Science in marketing, Susquehanna University, MBA, Northwestern University, Kellogg School of Management
- **Known for:** Led GE HealthCare through its separation from GE and January 2023 Nasdaq debut., Led Integra LifeSciences as president and CEO from January 2012 through December 2021., GE’s June 2021 appointment announcement credited his Integra tenure with doubling EBITDA and quintupling market value.

## Career timeline

- **1986** — Graduated from Susquehanna University; began his career in sales and marketing at Procter & Gamble.
- **1990-2005** — First fifteen-year tenure at GE, including U.S. sales, services and global business leadership.
- **2005-2010** — Led Baxter Healthcare’s Medication Delivery division.
- **2010** — Joined Integra LifeSciences as president and chief operating officer in November.
- **2012** — Became Integra LifeSciences president and CEO on January 3.
- **2016** — Joined the Bristol Myers Squibb board.
- **2022** — Returned to GE as president and CEO of its healthcare business on January 3.
- **2023** — Led GE HealthCare into independence; shares began trading on Nasdaq on January 4.
- **2023-2025** — Served as AdvaMed board chair; successor Mick Farrell’s term began in January 2026.

## Achievements

- Led GE HealthCare through its separation from GE and January 2023 Nasdaq debut.
- Led Integra LifeSciences as president and CEO from January 2012 through December 2021.
- GE’s June 2021 appointment announcement credited his Integra tenure with doubling EBITDA and quintupling market value.
- Named to Modern Healthcare’s 2023 list of 100 Most Influential People.
- Elected chair of the AdvaMed board in 2023 and served through 2025.

## Latest updates

- **2026-03** — The 2026 proxy statement described Arduini’s 2025 work deploying Heartbeat, the company’s business system, and strengthening leadership and operating processes.
- **2026-03** — His 2025 annual-report letter set out 2026 priorities including disciplined execution, operational excellence, innovation investment and stockholder value.
- **2026-01** — Mick Farrell succeeded him as AdvaMed chair; Arduini remains listed on the association’s board.

## Links

- Website: https://www.gehealthcare.com
- LinkedIn: https://www.linkedin.com/in/peter-j-arduini

---

Profile page: https://yespress.io/peter-arduini
Published by YesPress — https://yespress.io
Last updated: 2026-10-21